Patent details

EP3490560 Title: NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER

Basic Information

Publication number:
EP3490560
PCT Application Number:
US2017044413
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177542263
PCT Publication Number:
WO2018023017
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NIRAPARIB FOR USE IN A METHOD OF TREATING PROSTATE CANCER
French Title of Invention:
NIRAPARIB POUR SON UTILISATION DANS UNE MÉTHODE DE TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
NIRAPARIB ZUR VERWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG VON PROSTATAKREBS
SPC Number:
LUC50015

Dates

Filing date:
28/07/2017
Grant date:
22/01/2025
EP Publication Date:
05/06/2019
PCT Publication Date:
01/02/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/01/2025
EP B1 Publication Date:
22/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/07/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/10/2025
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

History of Owners

From:
25/09/2025
To:
24/10/2025

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

From:
15/01/2025
To:
25/09/2025

Name:
Janssen Pharmaceutica, N.V.
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
NOVAGRAAF BREVETS
From:
28/01/2025
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
HAWKINS, Rebecca
Address:
Panama (PA)

2

Name:
GOTTARDIS, Marco
Address:
United States (US)

3

Name:
YAMADA, Douglas H.
Address:
United States (US)

4

Name:
SNYDER, Linda
Address:
United States (US)

Priority

1

Priority Number:
201662368466 P
Priority Date:
29/07/2016
Priority Country:
United States (US)

2

Priority Number:
201662369239 P
Priority Date:
01/08/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/454; A61P 35/00;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2025/12
Publication date:
07/11/2025
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202504
Publication date:
22/01/2025
Description:
Grant (B1)

2

Issue number:
202509
Publication date:
26/02/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202548
Publication date:
26/11/2025
Description:
Change of owner's name or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20250000352A
Date Registered:
25/09/2025
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
changement de nom
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/07/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
28/01/2025 Power Of Attorney 1
29/01/2025 Outgoing Correspondence 1
25/09/2025 Request For Change 1
01/10/2025 Outgoing Correspondence 1